Literature DB >> 15881662

Altered structure and expression of RB1 gene and increased phosphorylation of pRb in human vestibular schwannomas.

R Thomas1, P D Antony Herold Prabhu, J Mathivanan, D Sivakumar, P N Jayakumar, B Indira Devi, S Satish, K V R Sastry, R Gope.   

Abstract

Tumor-specific alterations at the RB1 gene locus in 30 human vestibular schwannomas including 10 NF2 and 20 sporadic cases were analysed. Southern blot analysis of DNA from these samples revealed loss of heterozygosity (LOH) at the RB1 locus in 6 of 24 informative cases (25%) compared to normal blood DNAs from the same patients. Northern blot analysis showed normal size RB1 mRNA in all the tumor samples. However, there was a 2-5-fold increase in the level of expression of the RB1 gene in all the tumor samples compared to the WI38 cell line which was used as control. Western blot analysis of the RB1 protein, pRb showed a 2.5-5-fold increase in the level of total pRb as compared to normal WI38 cell line. Sixty five to seventy five percent of the total pRb were in phosphorylated form in most tumors. The LOH at the RB1 gene locus suggests genetic instability in these patients. Further, increased levels of RB1 mRNA, total pRb and the phosphorylated form of pRb suggests that RB1 gene in these tumors may have anti-apoptotic function. These results suggest that the RB1 gene has a major role in the development of human vestibular schwannomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15881662     DOI: 10.1007/s11010-005-5617-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

Review 1.  The regulation of E2F by pRB-family proteins.

Authors:  N Dyson
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

2.  The expanding role of cell cycle regulators.

Authors:  T Jacks; R A Weinberg
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

Review 3.  A mutator phenotype in cancer.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

4.  Abundance and state of phosphorylation of the retinoblastoma susceptibility gene product in human colon cancer.

Authors:  R Gope; M L Gope
Journal:  Mol Cell Biochem       Date:  1992-03-25       Impact factor: 3.396

5.  The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression.

Authors:  A Borg; Q X Zhang; P Alm; H Olsson; G Sellberg
Journal:  Cancer Res       Date:  1992-05-15       Impact factor: 12.701

6.  Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas.

Authors:  V Gouyer; S Gazzeri; E Brambilla; I Bolon; D Moro; P Perron; A L Benabid; C Brambilla
Journal:  Int J Cancer       Date:  1994-09-15       Impact factor: 7.396

7.  Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16INK4 protein in gallbladder carcinomas.

Authors:  Y Z Shi; A M Hui; X Li; T Takayama; M Makuuchi
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

8.  Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.

Authors:  Sunanda J Chatterjee; Ben George; Peter J Goebell; Mohammad Alavi-Tafreshi; Shan-Rong Shi; Yuen Kai Fung; Peter A Jones; Carlos Cordon-Cardo; Ram H Datar; Richard J Cote
Journal:  J Pathol       Date:  2004-07       Impact factor: 7.996

9.  Retinoblastoma-cyclin-dependent kinase pathway deregulation in vestibular schwannomas.

Authors:  John M Lasak; D Bradley Welling; Elena M Akhmametyeva; Mariah Salloum; Long-Sheng Chang
Journal:  Laryngoscope       Date:  2002-09       Impact factor: 3.325

10.  Inhibition of apoptosis by the retinoblastoma gene product.

Authors:  D A Haas-Kogan; S C Kogan; D Levi; P Dazin; A T'Ang; Y K Fung; M A Israel
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  4 in total

1.  Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth.

Authors:  Sonam Dilwali; Martijn C Briët; Shyan-Yuan Kao; Takeshi Fujita; Lukas D Landegger; Michael P Platt; Konstantina M Stankovic
Journal:  Mol Oncol       Date:  2015-03-31       Impact factor: 6.603

2.  miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways.

Authors:  Okay Saydam; Ozlem Senol; Thomas Würdinger; Arda Mizrak; Gokhan Baris Ozdener; Anat O Stemmer-Rachamimov; Ming Yi; Robert M Stephens; Anna M Krichevsky; Nurten Saydam; Gary J Brenner; Xandra O Breakefield
Journal:  Cancer Res       Date:  2010-12-13       Impact factor: 12.701

3.  Altered structure and deregulated expression of the tumor suppressor gene retinoblastoma (RB1) in human brain tumors.

Authors:  J Mathivanan; K Rohini; Mohan L Gope; B Anandh; Rajalakshmi Gope
Journal:  Mol Cell Biochem       Date:  2007-02-23       Impact factor: 3.396

4.  BAY 61-3606, CDKi, and sodium butyrate treatments alter gene expression in human vestibular schwannomas and cause cell death in vitro.

Authors:  Rohan Mitra; Indira Devi Bhagavatula; Rajalakshmi Gope
Journal:  Ecancermedicalscience       Date:  2012-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.